Clinical Trial Update: Evaluation of Thermocool SF Catheter on the Common Cavo-tricuspid Isthmus Dependent Atrial Flutter Ablation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using the ThermoCool SF Catheter for cavotricuspid isthmus–dependent atrial flutter ablation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Flutter

Drugs mentioned

• ThermoCool SF Catheter

Snippet

Sponsor: Hospital Universitario Central de Asturias | Conditions: Atrial Flutter. | Phase 4 | Status: UNKNOWN